On Oct 14, Healthway Medical Corporation executive director and deputy chief executive officer Abram Suhardiman acquired 3,226,800 shares of the Catalist-listed company for a consideration of S$103,258.

 

At 3.2 cents per share, this took his total interest in Healthway Medical Corporation from 0.86 per cent to 0.93 per cent.

 

This followed his acquisition of 30.5 million shares, also at 3.2 cents per share on Oct 7.

 

He is responsible for overseeing the group' s operations and corporate support functions including finance, legal, marketing, human resources, corporate communications and information technology divisions.

 

He also assists the chief executive officer in strategic planning and managing all aspects of the company and the group' s business.

 

Prior to joining Healthway, he served as vice-president at Nuvest Capital.

 

He has also worked at The Abraaj Group and Citibank where he was part of the investment team in Southeast Asia.